Inari Medical, Inc. (NARI) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Irvine, CA, アメリカ. 現CEOは Kevin Strange.
NARI を有する IPO日 2020-05-22, 1,300 名の正社員, に上場 NASDAQ Global Select, 時価総額 $4.68B.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
